ATE520408T1 - Zubereitung zur behandlung von mineralstoffmangel - Google Patents

Zubereitung zur behandlung von mineralstoffmangel

Info

Publication number
ATE520408T1
ATE520408T1 AT06824296T AT06824296T ATE520408T1 AT E520408 T1 ATE520408 T1 AT E520408T1 AT 06824296 T AT06824296 T AT 06824296T AT 06824296 T AT06824296 T AT 06824296T AT E520408 T1 ATE520408 T1 AT E520408T1
Authority
AT
Austria
Prior art keywords
preparation
treatment
mineral
mineral deficiency
deficiency
Prior art date
Application number
AT06824296T
Other languages
English (en)
Inventor
Theodoor Maximiliaan Slaghek
Lawrence Fabian Batenburg
Hartmut Rudolf Fischer
Jan Matthijs Jetten
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of ATE520408T1 publication Critical patent/ATE520408T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06824296T 2005-12-07 2006-12-07 Zubereitung zur behandlung von mineralstoffmangel ATE520408T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05077820A EP1795202A1 (de) 2005-12-07 2005-12-07 Vorbereitung für die Behandlung des Mineralfehlbetrags
PCT/NL2006/000620 WO2007067043A1 (en) 2005-12-07 2006-12-07 Preparation for treatment of mineral deficiency

Publications (1)

Publication Number Publication Date
ATE520408T1 true ATE520408T1 (de) 2011-09-15

Family

ID=35840028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06824296T ATE520408T1 (de) 2005-12-07 2006-12-07 Zubereitung zur behandlung von mineralstoffmangel

Country Status (5)

Country Link
US (1) US20090092680A1 (de)
EP (2) EP1795202A1 (de)
AT (1) ATE520408T1 (de)
MY (1) MY148828A (de)
WO (1) WO2007067043A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI382842B (zh) * 2010-09-23 2013-01-21 Univ Nat Chunghsing 快速製備磷結合劑的方法及含磷結合劑的醫藥組合物
MX382942B (es) * 2015-12-15 2025-03-13 Univ Guadalajara Nanoparticulas de hidróxidos dobles laminares que contienen compuestos no polares de origen vegetal, método de separación y liberación selectiva de dichos compuestos
KR102481595B1 (ko) 2019-07-10 2022-12-26 엘지전자 주식회사 항균 글라스 조성물 및 이의 제조방법
JP7392976B2 (ja) * 2019-11-22 2023-12-06 株式会社海水化学研究所 ミネラル補給剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539306A (en) 1966-07-25 1970-11-10 Kyowa Chem Ind Co Ltd Process for the preparation of hydrotalcite
US4296094A (en) 1980-06-02 1981-10-20 Kyowa Chemical Industry Co., Ltd. Dental cleaning composition and method
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
GB9223604D0 (en) * 1992-11-11 1992-12-23 Unilever Plc Cosmetic composition
GB9226685D0 (en) * 1992-12-22 1993-02-17 Unilever Plc Deodorant compositions
GB9424445D0 (en) * 1994-12-02 1995-01-18 Unilever Plc Cosmetic composition
JPH10101569A (ja) * 1996-10-01 1998-04-21 Eisai Co Ltd 制酸剤
JP3278631B2 (ja) * 1999-04-06 2002-04-30 科学技術振興事業団 アニオン−層状複水酸化物層間化合物の製法及びその製造物
ES2168226B1 (es) * 2000-11-27 2003-09-16 Recuperat Ion Electrolitos S L Composicion que comprende sodio, potasio, calcio y magnesio.
GB0030460D0 (en) * 2000-12-14 2001-01-24 Isis Innovation Drug delivery system
JP2004091421A (ja) * 2002-09-03 2004-03-25 Tayca Corp アスコルビン酸を取り込んだ層状複水酸化物およびそれを含む化粧料組成物
US8227046B2 (en) * 2002-11-29 2012-07-24 Council Of Scientific And Industrial Research Process for preparing self-assembling nanobinary and ternary oxy/hydroxides
US20060013893A1 (en) * 2004-07-19 2006-01-19 Stockel Richard F Bisphosphonates inorganic carriers

Also Published As

Publication number Publication date
EP1965810B1 (de) 2011-08-17
EP1795202A1 (de) 2007-06-13
EP1965810A1 (de) 2008-09-10
MY148828A (en) 2013-06-14
US20090092680A1 (en) 2009-04-09
HK1122496A1 (en) 2009-05-22
WO2007067043A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
CY1110901T1 (el) Στερεοϊσομερεις ενωσεις και μεθοδοι για την αγωγη γαστρεντερικων διαταραχων και διαταραχων του κεντρικου νευρικου συστηματος
GB0710529D0 (en) Vaccine
ZA200709535B (en) Methods and compositions for the treatment of CNS-related conditions
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
ATE513761T1 (de) Verfahren zum behandeln von geweben
TW200716141A (en) Compositions and methods for treatment for neoplasms
TN2009000214A1 (en) Manufacture process
MX354099B (es) Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
WO2006091459A3 (en) Compositions and methods for treating vascular permeability
TWI319708B (en) Methods and compositions for altering cell fuction
IL199741A0 (en) Heterocyclic-substituted piperidine as orl-1 ligands
GB2442915B (en) Perylenequinone derivatives and uses thereof
WO2007005300A3 (en) Treatment of dry eye
MA29266B1 (fr) Traitement de tumeurs metastatiques
ATE494890T1 (de) Alpha-aminoamid-derivate zur behandlung von suchtstörungen
DE602005008241D1 (de) Zusammensetzung mit einem survivin-antisense-oligonucleotid und gemcitabin zur behandlung von krebs
EA200970817A1 (ru) Лекарственная форма, содержащая 1{6-[(3-циклобутил-2,3,4,5-тетрагидро-1н-3-бензазепин-7-ил)окси]-3-пиридинил}-2-пирролидинон или его соль и стабилизатор, который уменьшает его деградацию
EA200701995A1 (ru) Способы уменьшения кальцификации
CR8696A (es) Beta-carbolinas utiles para tratar enfermedades inflamatorias
BRPI0607850A2 (pt) método para o tratamento de materiais contendo cobre
MY148828A (en) Preparation for treatment of mineral deficiency
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
WO2009151618A3 (en) Methods and compositions for treating alzheimer's disease
MX2007016373A (es) Compuestos de piridil y piridonil estereoisomericos y metodos para el tratamiento de trastornos gastrointestinales y del sistema nervioso central.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties